T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRO
1076
DELISTED
Marathon Oil Corporation
MRO
| $21.3M | ﹤0.01% |
1,420,857
+990
| +0.1% | +$13.1K |
|
1077
Dover
DOV
$27.9B
| $21.3M | ﹤0.01% |
380,392
+2,974
| +0.8% | +$160K |
|
1078
Oil-Dri
ODC
$1.28B
| $21.2M | ﹤0.01% |
1,230,700
+2,800
| +0.2% | +$46.7K |
|
|
SCG
1079
DELISTED
Scana
SCG
| $21.2M | ﹤0.01% |
279,993
-4,075
| -1% | -$285K |
|
1080
KLA
KLAC
$279B
| $21M | ﹤0.01% |
2,863,850
+15,000
| +0.5% | +$108K |
|
|
ININ
1081
DELISTED
Interactive Intelligence Group, inc.
ININ
| $20.9M | ﹤0.01% |
510,542
-259,352
| -34% | -$10.1M |
|
|
CLVS
1082
DELISTED
Clovis Oncology, Inc.
CLVS
| $20.9M | ﹤0.01% |
1,520,794
-43,811
| -3% | -$640K |
|
|
SRCL
1083
DELISTED
Stericycle Inc
SRCL
| $20.7M | ﹤0.01% |
198,405
-2,400
| -1% | -$257K |
|
|
LLL
1084
DELISTED
L3 Technologies, Inc.
LLL
| $20.6M | ﹤0.01% |
140,655
+928
| +0.7% | +$125K |
|
1085
Waters Corp
WAT
$40.8B
| $20.6M | ﹤0.01% |
146,546
-110
| -0.1% | -$14.9K |
|
|
STRZA
1086
DELISTED
Starz - Series A
STRZA
| $20.6M | ﹤0.01% |
687,692
+25,896
| +4% | +$689K |
|
1087
Principal Financial Group
PFG
$24.5B
| $20.6M | ﹤0.01% |
500,126
-20,700
| -4% | -$874K |
|
1088
F5
FFIV
$23.7B
| $20.5M | ﹤0.01% |
179,905
-12,300
| -6% | -$1.32M |
|
|
ACBI
1089
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $20.5M | ﹤0.01% |
1,415,350
+1,286,985
| +1,003% | +$18.2M |
|
|
HTWR
1090
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $20.5M | ﹤0.01% |
354,173
-52,080
| -13% | -$1.7M |
|
|
DRII
1091
DELISTED
DIAMOND RESORTS INTL, INC
DRII
| $20.4M | ﹤0.01% |
679,780
-29,600
| -4% | -$670K |
|
|
AZPN
1092
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $20.3M | ﹤0.01% |
504,621
+17,610
| +4% | +$709K |
|
1093
Stewart Information Services
STC
$2.03B
| $20.2M | ﹤0.01% |
487,435
-37,029
| -7% | -$1.36M |
|
|
PRXL
1094
DELISTED
Parexel International Corp
PRXL
| $20.2M | ﹤0.01% |
320,490
-1,990
| -0.6% | -$123K |
|
|
BIG
1095
DELISTED
Big Lots, Inc.
BIG
| $20.1M | ﹤0.01% |
401,586
+1,026
| +0.3% | +$48.6K |
|
1096
Cincinnati Financial
CINF
$26.5B
| $20M | ﹤0.01% |
267,274
+9,470
| +4% | +$642K |
|
|
NAME
1097
DELISTED
Rightside Group, Ltd.
NAME
| $20M | ﹤0.01% |
1,875,774
+153,478
| +9% | +$1.38M |
|
1098
Churchill Downs
CHDN
$6.16B
| $19.9M | ﹤0.01% |
944,412
+164,352
| +21% | +$3.62M |
|
1099
Wynn Resorts
WYNN
$10.6B
| $19.7M | ﹤0.01% |
217,551
-2,000
| -0.9% | -$190K |
|
1100
PDF Solutions
PDFS
$2.15B
| $19.7M | ﹤0.01% |
1,408,031
-466,930
| -25% | -$6.35M |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.